Focal Therapeutics Release: Multiple Benefits Of Biozorb Surgical Marker Reported At BC3 Breast Cancer Conference

Published: Feb 26, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--The BioZorbâ„¢ three-dimensional surgical marker improved targeting for radiation therapy by enhancing visualization of the breast cancer lumpectomy cavity, according to a presentation at the 2014 Breast Cancer Coordinated Care (BC3) conference in Washington D.C.

Help employers find you! Check out all the jobs and post your resume.

Back to news